Rezivertinib
Rezivertinib (BPI-7711) is an orally available, selective and potent inhibitor of tyrosine kinase (EGFR) with antitumor activity for central nervous system disorders.
Product Specifications
CAS Number
1835667-12-3
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
486.57
Molecular Formula
C27H30N6O3
Notes
Research use only, not for human use.
Receptor
EGFR
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
